India Medical Device Crisis: Polypropylene Surge and Gas Rationing

The intersection of geopolitical conflict and domestic energy constraints has pushed India's medical device industry into a precarious position, threatening the stability of healthcare delivery nationwide. The ongoing war involving Iran has triggered a dramatic spike in the cost of polypropylene (PP), a critical thermoplastic polymer that serves as the primary raw material for a vast array of medical consumables. Industry experts report that PP prices have jumped by over Rs 55 per kg since December, with a staggering 25-35% surge occurring in the first two weeks of March 2026 alone. This level of price volatility is being described by industry veterans as unprecedented, even surpassing the supply chain shocks witnessed during the height of the COVID-19 pandemic.

Polypropylene is the backbone of modern medical manufacturing, essential for the production of syringes, IV bags, catheter components, blood bags, and surgical drapes. The sudden inflation in material costs is particularly devastating for India's medical device ecosystem, where small and medium enterprises (SMEs) represent approximately 90% of the sector. These smaller manufacturers typically operate on thin margins and lack the capital reserves or long-term hedging contracts necessary to absorb such rapid cost increases. Himanshu Baid, Managing Director of Polymedicure, notes that the current environment of 'price gouging' and logistics disruptions is making it increasingly difficult for exporters and domestic suppliers to fulfill orders.

“

Polypropylene is the backbone of modern medical manufacturing, essential for the production of syringes, IV bags, catheter components, blood bags, and surgical drapes.

Compounding the raw material crisis is a deepening energy squeeze within India. Adani Total Gas has implemented a strict gas rationing policy, informing manufacturers that they will receive only up to 40% of their daily contracted quantity at standard rates. Any consumption exceeding this 40% threshold is classified as 'excess gas' and subjected to significantly higher pricing. For energy-intensive manufacturing processes like plastic injection molding used in syringe production, this rationing acts as a secondary tax on production, further squeezing the margins of companies already reeling from high polymer costs. The dual pressure of expensive raw materials and restricted energy creates a 'pincer movement' that could force many smaller plants to suspend operations.